GENB
Financials
- Market Capitalization 1.82 B
- Employee 312
- Founded 2018
- CEO N/A
- Website www.generatebiomedicines.com
- Headquarter Delaware, United States
- FIGI BBG00X9D0NZ0
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1930 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 149.68 USD | +2.50% | +5.18% | +27.93% | +102.68% | 2.15 B USD | ||
| 1990 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 41.46 USD | +2.14% | +4.35% | +7.86% | +58.30% | 1.98 B USD | ||
| 2131 |  MAZE Maze Therapeutics, Inc. - Common Stock | 29.88 USD | +2.40% | -9.01% | +23.68% | -33.64% | 1.65 B USD | ||
| 2861 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.19 USD | -2.39% | -10.06% | +7.15% | -40.23% | 551.67 M USD |
Frequently asked questions about Generate Biomedicines, Inc. - Common Stock
What is the Generate Biomedicines, Inc. - Common Stock stock price today?
The current price of Generate Biomedicines, Inc. - Common Stock (GENB) is 14.21. Over the past 24 hours, the stock has changed by -0.49%. Follow the GENB chart for real-time price dynamics.
What is the stock ticker of Generate Biomedicines, Inc. - Common Stock?
Generate Biomedicines, Inc. - Common Stock trades under the ticker GENB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Generate Biomedicines, Inc. - Common Stock stock going up?
GENB has changed by -9.66% over the last week, +5.57% over the last month, and -5.27% over the last year. Review the chart to see whether the current move is part of a broader trend.
How many employees does Generate Biomedicines, Inc. - Common Stock have?
As of the latest available data, Generate Biomedicines, Inc. - Common Stock has 312 employees. Workforce size can provide additional context about the company's scale and operations.
What is Generate Biomedicines, Inc. - Common Stock EBITDA?
Generate Biomedicines, Inc. - Common Stock EBITDA is -60.84 M, and its EBITDA margin is -842.18%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Generate Biomedicines, Inc. - Common Stock stock?
You can buy Generate Biomedicines, Inc. - Common Stock (GENB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Generate Biomedicines, Inc. - Common Stock stock?
Investing in Generate Biomedicines, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GENB chart and related analysis on metatrader.com as part of your research.